1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Faron Pharmaceuticals Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Patients Having Acute Respiratory Distress Syndrome (ARDS) Interferon beta-1a, Placebo - Respiratory Distress Syndrome, Adult | Phase 3 | Terminated | Faron Pharmaceuticals Ltd | 301 | 2015-12-23 | 2020-03-30 |
Respiratory Distress Syndrome (1) · Respiratory Insufficiency (1)
Belgium (1) · Czechia (1) · Finland (1) · France (1) · Germany (1) · Italy (1) · Spain (1) · United Kingdom (1)
Geoffrey Bellingan, MD (1) · V Marco Ranieri, Prof. MD (1)
2014 (1)